CCL2 and neoplasm: It has been shown that in in vitro experiments of human cancer models, secretion of tumor-derived CCL2 attracts CCR2 expressing MDSCs towards the cytokine [21], with evidence provided by Guan et al. positively correlating the amount of CCL2 to MDSC accumulation and immunosuppressive capacity [33].